Guillain–Barré syndrome following different COVID-19 vaccines: a case series

BACKGROUND: The COVID-19 vaccine-related Guillain–Barré syndrome (GBS) has been described for both messenger-RNA vaccine and adenovirus-vectored types in a few cases with great public concern and the necessity to inform physicians about the variations of its presentations given its life-threatening...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalash, Ali, Belal, Nourhan, Zaki, Amr S., Georgy, Shady S., Doheim, Mohamed Fahmy, Hazzou, Ahmed, Abdelnasser, Azza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734843/
https://www.ncbi.nlm.nih.gov/pubmed/36532828
http://dx.doi.org/10.1186/s41983-022-00582-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734843/
https://www.ncbi.nlm.nih.gov/pubmed/36532828
http://dx.doi.org/10.1186/s41983-022-00582-7

Ejemplares similares